Factors that influence the recruitment of patients to phase III studies in oncology: The perspective of the clinical research associate

Cancer

Volumn 95, Issue 7, 2002, Pages 1584-1591

  Wright, James R ^a,b   Crooks, Dauna ^c   Ellis, Peter M ^a,b   Mings, Deborah ^d   Whelan, Tim J ^a,b,c  

^a JURAVINSKI CANCER CENTRE   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d St Peter's Hospital   (Canada)

Author keywords

Clinical research associate; Clinical trial recruitment; Focus group; Patient participation

Indexed keywords

ARTICLE; CANCER RESEARCH; CLINICAL TRIAL; DECISION MAKING; HUMAN; INFORMED CONSENT; PATIENT; PATIENT SELECTION; PHYSICIAN; PRIORITY JOURNAL;

ATTITUDE OF HEALTH PERSONNEL; CANCER CARE FACILITIES; CLINICAL TRIALS, PHASE III; DECISION MAKING; FOCUS GROUPS; HUMANS; PATIENT PARTICIPATION; PATIENT SELECTION; PHYSICIAN-PATIENT RELATIONS;

EID: 0036785416     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10864     Document Type: Article

References (32)

1. Begg CB. Selection of patients for clinical trials. Semin Oncol. 1988;15:434-440.
2. Wittes RE, Friedman MA. Accrual to clinical trials. J Natl Cancer Inst. 1998;80:884-885.
3. American Medical Association Council on Scientific Affairs. Viability of cancer clinical research: patient accrual, coverage, and reimbursement. J Natl Cancer Inst. 1991;83:254-259.
4. Fischer B. Clinical trial participation. J Clin Oncol. 1991;9:1927-1930.
5. Winn RJ. Obstacles to the accrual of patients to clinical trials in the community setting. Semin Oncol. 1994;21:(4 Suppl 7);112-117.
6. Bacon M. The evolving role of nurses in clinical trials. Can Oncol Nurs J. 1997;7:79-80.
7. Bujorian GA. Clinical trials: patient issues in the decision-making process. Oncol Nurs Forum. 1988;15:779-783.
8. McEvoy MD, Cannon L, DacDermott ML. The professional role for nurses in clinical trials. Semin Oncol Nurs. 1991;7:268-274.
9. Engelking C. Facilitating clinical trials-the expanding role of the nurse. Cancer. 1991;67:1793-1797.
10. Aaronson NK, Visser-Pol E, Leenhouts GH, et al. Telephone-based nursing intervention improves the effectiveness of the informed consent process in cancer clinical trials. J Clin Oncol. 1996;14:984-996.
11. Kaye JM, Lawton P, Kaye D. Attitudes of elderly people about clinical research on aging. Gerontologist. 1990;30:100-106.
12. Ellis PM. Attitudes towards and participation in randomised clinical trials in oncology: a review of literature. Ann Oncol. 2000;11:939-945.
13. Taylor KM, Kelner M. Interpreting physician participation in randomised clinical trials: the Physician Orientation Profile. J Health Soc Behav. 1987;28:389-400.
14. Taylor KM, Margolese RG, Soskolne CL. Physicians' reasons for not entering eligible patients in a randomised clinical trial of surgery for breast cancer. N Engl J Med. 1984;310:1363-1367.
15. Langley GR, Sutherland HJ, Wong S, et al. Why are (or are not) patients given the option to enter clinical trials? Control Clin Trials. 1987;8:49-59.
16. Benson AB, Pregler JP, Bean JA, et al. Oncologists' reluctance to accrue patients on to clinical trials: an Illinois Cancer Center study. J Clin Oncol. 1991;9:2067-2075.
17. McCusker J, Wax A, Bennett JM. Cancer patient accessions into clinical trials. Am J Clin Oncol. 1982;5:227-236.
18. Winn RJ, Miransky J, Kerner JF, et al. An evaluation of physician determinants in the referral of patients for cancer clinical trials in the community setting. In: Engstrom PF, Anderson PN, Mortenson LE, editors. Advances in cancer control: epidemiology and research. New York: Alan R. Liss, Inc., 1984:63-73.
19. Llewellyn-Thomas HA, McGreal MJ, Thiel ZC, et al. Patients willingness to enter clinical trials: measuring the association with perceived benefit and preference for decision participation. Soc Sci Med. 1991;32:35-42.
20. Seldon JM, Fetting JH, Siminoff LA. Offering the option of randomized clinical trials to cancer patients who overestimate their prognosis with standard therapies. Cancer Invest. 1993;11:57-62.
21. Kass NE, Sugarman J, Faden R, Schoch-Spana M. Trust: the fragile foundation of contemporary biomedical research. Hastings Center Rep. 1996;26:25-29.
22. Mackillop WI, Palmer MJ, O'Sullivan B, et al. Clinical trials in cancer: the role of surrogate patients in defining what constitutes an ethically acceptable clinical experiment. Br J Cancer. 1989;50:388-395.
23. Krueger RA. Focus groups: a practical guide for applied research. Thousand Oaks, CA: Sage, 1994.
24. Carey MA, Smith MW. Capturing the group effect in focus groups: a special concern in analysis. Qualitative Health Res. 1994;4:123-127.
25. Morgan DL. Focus groups as qualitative research. Newbury Park, CA: Sage, 1988.
26. Bernard H. Research methods in anthropology: qualitative and quantitative approaches. Thousand Oaks, CA: Sage, 1994.
27. Ellis PM, Dowsett SM, Butow PH, Tattersal MHN. Attitudes to randomized clinical trials amongst outpatients attending a medical oncology clinic. Health Expectations. 1999;2:33-34.
28. Albrecht TL, Blanchard C, Ruckdeschel JC, et al. Strategic physician communication and oncology clinical trials. J Clin Oncol. 1999;17:3324-3332.
29. Grant CH, Cissna KN, Rosenfeld LB. Patients' perceptions of physicians communication and outcomes of the accrual to trial process. Health Comm. 2000;12:23-39.
30. Brown JB, Boles M, Mullooly JP, Levinson W. Effect of clinician communication skills training on patient satisfaction. A randomized, controlled trial. Ann Intern Med. 1999;131:859-860.
31. Fallowfield L, Ratcliffe D, Souhami R. Clinicians' attitudes to clinical trials of cancer therapy. Eur J Cancer 1997;33:2221-2229.
32. Siminoff LA, Fetting JH, Abeloff MD. Doctor-patient communication about breast cancer adjuvant therapy. J Clin Oncol. 1980;7:1192-1200.